binx health is a first-of-kind population health technology company that brings high quality convenient testing to the places where people live, work, study and shop. The Company works with large corporate partners and institutions to keep millions of people healthy and businesses and schools open. Its CLIA-waived, molecular point-of-care io platform puts central-lab quality testing solutions in the hands of clinicians everywhere. This includes the rapidly expanding ecosystem of retail health and the Company’s suite of medically guideline-driven, at-home sample collection offerings which bring high quality testing and population health tools and digital integration capability to large corporate partners and those unable to visit a clinic location.
binx’ FDA-cleared, CLIA-waived io platform is the first ever point-of-care tool for the detection of chlamydia and gonorrhea that provides central lab performance results in about thirty minutes. Its platform is highly flexible, easy-to-use, and rapid, offering molecular point-of-care answers at central-lab quality performance and for the first time enabling single-visit test and treatment. The Company is currently expanding its platform into COVID-19 testing by combining our proprietary electrochemical detection with CRISPR methods. We are building solutions designed for the future of healthcare that lies at the nexus of testing convenience, rigorous science, and strong consumer relationships.


Read more about our company, people, and culture.


binx aims to transform the way people consume healthcare by offering testing solutions in the locations and in the ways most convenient for them. We do this by focusing on two distinct populations: those who visit physical locations for care and those who do not. Across virtually all categories of routine healthcare, there exist these two populations of patients, regardless of call point (primary care, retail pharmacy, urgent care centers, student health, etc.) and regardless of disease or disorder (sexual health, respiratory infections, cancer screening, COVID-19, etc.): (i) those who show up for care at clinics and other locations, and (ii) those who do not, choosing to stay home for a variety of reasons. By tailoring our test delivery systems to these healthcare consumption patterns, we have the opportunity to change the way people think about and seek routine testing and, we believe, to vastly expand the universe of people who receive proper, high quality and convenient testing.
binx is ever-expanding, constantly innovating, and always on the lookout for enthusiastic, innovative, and talented candidates who share our common goal.